Tag: Hong Kong IPO
Firms act on snack retailer Busy Ming’s HKD3.67bn HKEX IPO
Snack retailer Busy Ming raised HKD 3.67 bn in its HKEX IPO. Clifford Chance, CM Law Firm, Cleary Gottlieb, Jingtian & Gongcheng and Han Kun advised on the transaction
Firms steer AI developer MiniMax’s HKD4.82bn Hong Kong IPO
Marking the largest IPO to date by an AI LLM company, advised by eight law firms
Firms guide Seres on debut, HK’s largest carmaker IPO in 2025
Seres Group raised USD1.83bn in its HKEX debut, Hong Kong’s largest carmaker IPO and third-biggest listing of 2025, advised by Davis Polk, KWM, Cooley, Haiwen and Han Kun
Embracing risk
As capital markets resurrect, how can businesses capitalise on opportunities amid risks and nagging uncertainties?
CATL’s HKD35.7bn HKEX debut reignites HK global IPO ambitions
CATL raised HKD35.7 billion in its Hong Kong debut, marking the city’s largest IPO in four years and accelerating the company’s global expansion
CATL’s HKD35.7bn HKEX debut reignites HK global IPO ambitions
China’s CATL raised HKD35.7 billion in Hong Kong’s largest IPO in four years, boosting its global expansion and the city’s fundraising stature
Chinese law firms make inroads on drafting prospectuses
In the last two months of 2023, at least three Chinese law firms have been writing prospectuses for IPOs in Hong Kong
Three law firms assist Weilong snack brand’s HKD898m Hong Kong IPO
Clifford Chance, Commerce & Finance Law Firm and Maples advised famous Chinese snack brand Weilong on its HKEX listing, raising HKD898 million from the sale of 96.4 million shares at HKD10.56 apiece
China’s YishengBio eyes US capital markets via SPAC route
Yisheng Biopharma has abandoned its Hong Kong IPO and turned instead to the Nasdaq via the SPAC route in a deal that is expected to be sealed by the first quarter of 2023
Three law firms guide smart drugs platform’s debut on Hong Kong bourse
A trio of law firms guided Chinese online pharmacy platform Dingdang Health in its Hong Kong IPO of ?HKD12 per share, raising HKD402.4 million (USD51 million)
Capital punishment
Chinese IPOs overseas have consistently outperformed those of other nations, but a rash of scandals and suspected frauds has threatened to end the bull run.





























